NoahAaronBrownMD

PubMed

• The EGFR T790M mutation is acquired through AICDA-mediated deamination of 5-methylcytosine following TKI treatment in lung cancer.
  El Kadi, N.,Wang, L.,Davis, A.,Korkaya, H.,Cooke, A.,Vadnala, V.,Brown, N. A.,Betz, B. L.,Cascalho, M.,Kalemkerian, G. P.,Hassan, K. A.> ;Cancer Res.. 1900 Jan 01
• Precision Medicine in Non-Small Cell Lung Cancer: Current Standards in Pathology and Biomarker Interpretation.
  Brown, N. A.,Aisner, D. L.,Oxnard, G. R.> ;Am Soc Clin Oncol Educ Book. 2018 Sep 21
• Clinical implications of oncogenic mutations in pulmonary Langerhans cell histiocytosis.
  Brown, N. A.,Elenitoba-Johnson, KSJ.> ;Curr Opin Pulm Med. 2018 Feb 23
• Polo-like-kinase 1 (PLK-1) and c-myc inhibition with the dual kinase-bromodomain inhibitor volasertib in aggressive lymphomas.
  Murga-Zamalloa, C.,Polk, A.,Hanel, W.,Chowdhury, P.,Brown, N.,Hristov, A. C.,Bailey, N. G.,Wang, T.,Phillips, T.,Devata, S.,Poonnen, P.,Gomez-Gelvez, J.,Inamdar, K. V....> ;Oncotarget. 2018 Feb 01
• A single center phase II study of ixazomib in patients with relapsed or refractory cutaneous or peripheral T-cell lymphomas.
  Boonstra, P. S.,Polk, A.,Brown, N.,Hristov, A. C.,Bailey, N. G.,Kaminski, M. S.,Phillips, T.,Devata, S.,Mayer, T.,Wilcox, R. A.> ;Am. J. Hematol.. 2017 Aug 27
• Human papillomavirus (HPV) and somatic EGFR mutations are essential, mutually exclusive oncogenic mechanisms for inverted sinonasal papillomas and associated sinonasal...
  Udager, A. M.,McHugh, J. B.,Goudsmit, C. M.,Weigelin, H. C.,Lim, M. S.,Elenitoba-Johnson, KSJ.,Betz, B. L.,Carey, T. E.,Brown, N. A.> ;Ann. Oncol.. 2017 Nov 18
• Blood-brain barrier-adapted precision medicine therapy for pediatric brain tumors.
  Marini, B. L.,Benitez, L. L.,Zureick, A. H.,Salloum, R.,Gauthier, A. C.,Brown, J.,Wu, Y. M.,Robinson, D. R.,Kumar, C.,Lonigro, R.,Vats, P.,Cao, X.,Kasaian, K.,Anderson...> ;Transl Res. 2017 Sep 02
• Cutaneous syncytial myoepithelioma: A recently described neoplasm which may mimic nevoid melanoma and epithelioid sarcoma.
  Alomari, A. K.,Brown, N.,Andea, A. A.,Betz, B. L.,Patel, R. M.> ;J. Cutan. Pathol.. 2017 Jul 15
• Comparative Study of TERT Promoter Mutation Status within Spatially, Temporally and Morphologically Distinct Components of Urothelial Carcinoma.
  Brown, N. A.,Lew, M.,Weigelin, H. C.,Weizer, A.,Montgomery, J.,Betz, B. L.,Mehra, R.> ;Histopathology. 2017 Jul 26
• Functional proteogenomics reveals biomarkers and therapeutic targets in lymphomas.
  Rolland, DCM.,Basrur, V.,Jeon, Y. K.,McNeil-Schwalm, C.,Fermin, D.,Conlon, K. P.,Zhou, Y.,Ng, S. Y.,Tsou, C. C.,Brown, N. A.,Thomas, D. G.,Bailey, N. G.,Omenn, G. S.,N...> ;Proc. Natl. Acad. Sci. U.S.A.. 2017 Jun 14
• Evaluation of Allele-Specific PCR and Immunohistochemistry for the Detection of BRAF V600E Mutations in Hairy Cell Leukemia.
  Brown, N. A.,Betz, B. L.,Weigelin, H. C.,Elenitoba-Johnson, K. S.,Lim, M. S.,Bailey, N. G.> ;Am. J. Clin. Pathol.. 2014 Dec 17
• Ameloblastoma: A Review of Recent Molecular Pathogenetic Discoveries.
  Brown, N. A.,Betz, B. L.> ;Biomark Cancer. 2015 Oct 21
• Join now to see all